Panjang

ACRX 60% then 300% PROFIT beats the 1% a day

Telah dikemas kini
Previous ratios support the drug success at a return to 10.35, with the pivot mark being at 60% gain.
Komen
August28
biotechChart PatternsstockpicksTrend Analysis

Penafian